ABSTRACT:
Rhabdomyosarcoma (RMS) is a malignant soft tissue neoplasm consisting of cells derived from the primitive mesenchyme that exhibit a profound tendency to myogenesis. About 35% of RMS arises in the head and neck,it is less frequent in oral cavity. These are the most common soft tissue sarcoma of the children, adolescents and young adults. Their etiopathogenesis and its molecular relevance have been emphasized. The first line of treatment is radical excision and this is usually supplemented by radiotherapy. It is believed that adjunct combination chemotherapy may greatly improve the prognosis. Inadequately treated tumours grow in an infiltrative manner and recur in a high percentage of cases. Bone does not constitute an effective barrier to the growth of the tumour and bone invasion is a frequent finding in head and neck rhabdomyosarcomas.
Cite this article:
P.S. Subiksha. Oral Rhabdomyosarcoma. Research J. Pharm. and Tech. 7(11): Nov. 2014 Page 1311-1314.
Cite(Electronic):
P.S. Subiksha. Oral Rhabdomyosarcoma. Research J. Pharm. and Tech. 7(11): Nov. 2014 Page 1311-1314. Available on: https://rjptonline.org/AbstractView.aspx?PID=2014-7-11-10